SAN DIEGO and SUZHOU, China, May  22, 2024  (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.

Adagene's Chairman, Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will provide a company update, including progress on the masked, anti-CTLA-4 SAFEbody ADG126. Company management will also host investor meetings.

Jefferies Global Healthcare Conference 2024

• Date: Wednesday, June 5

• Time: 4:30-4:55 PM (Eastern Time)

• Location: New York City

Goldman Sachs 45th Annual Global Healthcare Conference

• Date: Thursday, June 13

• Time: 10:00-10:35 AM (Eastern Time)

• Location: Miami

HC Wainwright 2nd Annual Immune Cell Engager Virtual Conference

• Date: Tuesday, June 25

• Time: TBD for presentation

• Location: Virtual

A live webcast of the presentations will also be accessible in the Investors section of the company's website. A webcast replay will be available for at least 30 days.